LATEST ALERTS
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised
In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
The presence of CBD could render cannabis useless as a treatment for glaucoma, new research warns. Long-term use of the substance may even worsen one of the main risk factors for the eye disease
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Most European CBD oils label their CBD content correctly but comparatively few are accurate about THC, a study in the Czech Republic has found
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
Dr Sanjay Gupta, president of the American Pain Association (APA), has called on US insurance companies to cover CBD treatments for patients
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO)
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis
A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness
Cannabidiol (CBD) could be helpful in smoking cessation, but the area is little researched and more work is required, says a London scientist who will soon publish a paper on the topic
Vaping is reported to be one of the best ways to absorb CBD, a cannabinoid present in cannabis which has relaxing and pain-relieving effects but produces no psychoactive “high”. E-liquid containing CBD is already on the market
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Notifications
